Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-01 Purchase | 2021-02-03 5:57 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 187,061 | $2.05 | $383,475 | 23,970,334 (Direct) | View |
| 2020-12-30 Purchase | 2021-01-04 5:10 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 6,325,213 | $2.5 | $15,813,033 | 23,783,273 (Direct) | View |
| 2020-12-30 Sale | 2020-12-31 6:48 pm | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 20,000 | $2.74 | $54,800 | 1,387 (Direct) | View |
| 2020-12-24 Purchase | 2020-12-29 4:56 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 631,600 | $2.6856 | $1,696,234 | 17,458,060 (Direct) | View |
| 2020-12-21 Purchase | 2020-12-23 5:50 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 1,565,000 | $2.599 | $4,067,400 | 16,826,460 (Direct) | View |
| 2020-12-21 Sale | 2020-12-22 7:51 pm | PDL BIOPHARMA INC. | PDLI | MCLAUGHLIN JOHN PETER Director | 327,934 | $2.6096 | $855,774 | 200,000 (Direct) | View |
| 2020-12-16 Purchase | 2020-12-18 5:35 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 1,748,000 | $2.5868 | $4,521,780 | 15,261,460 (Direct) | View |
| 2020-12-16 Sale | 2020-12-17 4:49 pm | PDL BIOPHARMA INC. | PDLI | Stone Christopher Lewis VP, Gen. Counsel & Secretary | 200,000 | $2.56 | $512,000 | 405,559 (Direct) | View |
| 2020-12-16 Sale | 2020-12-17 4:48 pm | PDL BIOPHARMA INC. | PDLI | Monnet Dominique President and CEO | 500,000 | $2.6 | $1,300,000 | 734,921 (Direct) | View |
| 2020-12-16 Sale | 2020-12-17 4:48 pm | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 75,000 | $2.68 | $201,000 | 21,387 (Direct) | View |
| 2020-12-11 Purchase | 2020-12-15 7:00 pm | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. O'Shea Robert J MULE EDWARD A 10% Owner | 2,090,000 | $2.569 | $5,369,300 | 13,513,460 (Direct) | View |
| 2020-12-03 Sale | 2020-12-04 9:17 pm | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 75,000 | $2.52 | $189,000 | 30,337 (Direct) | View |
| 2020-11-23 Sale | 2020-11-24 7:25 pm | PDL BIOPHARMA INC. | PDLI | O'Farrell Elizabeth G. Director | 25,826 | $2.44 | $63,015 | 0 (Direct) | View |
| 2020-11-23 Sale | 2020-11-24 7:25 pm | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 50,000 | $2.43 | $121,500 | 105,337 (Direct) | View |
| 2020-11-18 Sale | 2020-11-20 8:22 pm | PDL BIOPHARMA INC. | PDLI | O'Farrell Elizabeth G. Director | 63,291 | $2.381 | $150,696 | 25,826 (Direct) | View |
| 2020-11-20 Sale | 2020-11-20 8:22 pm | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 33,435 | $2.4227 | $81,003 | 10,438 (Direct) | View |
| 2020-11-17 Sale | 2020-11-19 5:33 pm | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 150,000 | $2.3967 | $359,500 | 95,337 (Direct) | View |
| 2020-09-29 Purchase | 2020-10-01 5:52 pm | LENSAR Inc. | LNSR | PDL BIOPHARMA INC. 10% Owner | 8,703 | $11.16 | $97,125 | 8,667,397 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-01-11 4:32 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Park West Asset Management LLC 10% Owner | 0 | $0 | 14,397,212 (Indirect) | View |
Ownership | 2020-12-15 6:58 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Silver Point Capital L.P. MULE EDWARD A O'Shea Robert J 10% Owner | 0 | $0 | 11,423,460 (Direct) | View |
| 2020-12-05 Exercise | 2020-12-09 7:46 pm | 2020-11-05 2029-06-19 | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 66,050 | $1.64 | 96,387 (Direct) | View |
| 2020-12-02 Disposition | 2020-12-04 9:17 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Stone Christopher Lewis VP, Gen. Counsel & Secretary | 11,544 | $0 | 605,559 (Direct) | View |
| 2020-11-18 Exercise | 2020-11-20 8:22 pm | 2020-11-05 2029-06-19 | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 60,000 | $1.64 | 221,387 (Direct) | View |
| 2020-11-18 Tax Withholding | 2020-11-20 8:22 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 26,642 | $2.38 | 10,438 (Direct) | View |
| 2020-11-18 Exercise | 2020-11-20 8:22 pm | 2021-04-17 2030-04-17 | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 37,080 | $1.71 | 10,438 (Direct) | View |
| 2020-10-01 Other | 2020-10-01 5:52 pm | N/A N/A | LENSAR Inc. | LNSR | PDL BIOPHARMA INC. 10% Owner | 8,667,397 | $0 | 8,667,397 (Direct) | View |
Ownership | 2020-09-17 6:13 pm | N/A N/A | LENSAR Inc. | LNSR | PDL BIOPHARMA INC. 10% Owner | 0 | $0 | 8,658,694 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:06 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Hernday Natasha Director | 25,826 | $0 | 194,497 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:06 am | 2021-08-19 2030-08-19 | PDL BIOPHARMA INC. | PDLI | Hernday Natasha Director | 118,671 | $3.63 | 194,497 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:06 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | MCLAUGHLIN JOHN PETER Director | 25,826 | $0 | 646,605 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:06 am | 2021-08-19 2030-08-19 | PDL BIOPHARMA INC. | PDLI | MCLAUGHLIN JOHN PETER Director | 118,671 | $3.63 | 646,605 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 25,826 | $0 | 152,106 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | 2021-08-19 2030-08-19 | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 118,671 | $3.63 | 152,106 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 25,826 | $0 | 364,008 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | 2021-08-19 2030-08-19 | PDL BIOPHARMA INC. | PDLI | GRYSKA DAVID W Director | 118,671 | $3.63 | 364,008 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | O'Farrell Elizabeth G. Director | 25,826 | $0 | 207,788 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-24 06:05 am | 2021-08-19 2030-08-19 | PDL BIOPHARMA INC. | PDLI | O'Farrell Elizabeth G. Director | 118,671 | $3.63 | 207,788 (Direct) | View |
| 2020-05-21 Other | 2020-05-26 4:43 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | PDL BIOPHARMA INC. 10% Owner | 13,333,334 | $0 | 13,333,334 (Direct) | View |
| 2020-04-17 Option Award | 2020-04-21 9:53 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 7,609 | $0 | 44,689 (Direct) | View |
| 2020-04-17 Option Award | 2020-04-21 9:53 pm | 2021-04-17 2030-04-17 | PDL BIOPHARMA INC. | PDLI | Bazaar Alan Lee Director | 37,080 | $3.07 | 44,689 (Direct) | View |
| 2019-12-16 Tax Withholding | 2020-04-07 08:48 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Stone Christopher Lewis VP, Gen. Counsel & Secretary | 2,686 | $3.33 | 617,103 (Direct) | View |
| 2019-12-12 Tax Withholding | 2020-04-07 08:48 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Stone Christopher Lewis VP, Gen. Counsel & Secretary | 1,240 | $3.43 | 617,103 (Direct) | View |
| 2020-01-08 Option Award(A) | 2020-04-07 08:47 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Imbrogno Edward VP Finance, CAO and Acting CFO | 292,208 | $0 | 314,565 (Direct) | View |
| 2020-01-08 Option Award(A) | 2020-04-07 08:47 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Monnet Dominique President and CEO | 1,233,766 | $0 | 1,907,426 (Direct) | View |
| 2020-01-08 Option Award(A) | 2020-04-07 08:46 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Jene Jill M. VP, Business Development | 194,805 | $0 | 194,805 (Direct) | View |
| 2020-01-08 Option Award(A) | 2020-04-07 08:46 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Stone Christopher Lewis VP, Gen. Counsel & Secretary | 422,078 | $0 | 617,103 (Direct) | View |
| 2020-02-07 Tax Withholding | 2020-04-07 08:46 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Imbrogno Edward VP Finance, CAO and Acting CFO | 82,488 | $3.51 | 232,077 (Direct) | View |
| 2020-02-07 Tax Withholding | 2020-04-07 08:45 am | N/A N/A | PDL BIOPHARMA INC. | PDLI | Monnet Dominique President and CEO | 672,505 | $3.51 | 1,234,921 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-10 6:37 pm | N/A N/A | PDL BIOPHARMA INC. | PDLI | Imbrogno Edward VP Finance, CAO and Acting CFO | 292,208 | $0 | 314,565 (Direct) | View |